Device Week, 10 March 2022 – Femtech Attracts Investors; ZimVie Fails To Impress Wall Street

In this edition of Device Week, Medtech Insight’s Barnaby Pickering discusses Zimmer Biomet’s recent spin-off of its spinal and dental businesses under the name ZimVie and editor Marion Webb explains the emerging field of femtech, which includes innovations to treat often-overlooked unmet needs in women’s health

Listen to the podcast via the player below:

 

The archive of Medtech Insight's Device Week and the rest of Informa Pharma Intelligence’s podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn, and Spotify Podcasts. 

Medtech Insight articles addressing topics discussed in this episode:

• Zimmer Biomet Spin-Off’s Share Price Plummets

• ‘Femtech’ Evolving Beyond Periods, Pregnancy And Postpartum: What’s Next In $1.2Tr Women’s Health